
NCBiotech on North Carolina Biomanufacturing Talent, Investment, and Geopolitics
“It’s an easy move to say, ‘Oh, you’re becoming victims of your own success. Where do I find my talent?’ And I would argue you’re going to find it exactly where you found it before, and there’s plenty of it,” says Bill Bullock. Bill Bullock is Senior Vice President of Economic and Statewide Development at the North Carolina Biotechnology Center (NCBiotech). He trained as a biochemist and worked at the bench for a California startup before doing an MBA at UNC Chapel Hill. He joined NCBiotech in 2003 to build out its economic development function, and has spent more than two decades bringing life sciences companies to the state. North Carolina now employs roughly 36,000 people in life sciences manufacturing. Since January 2022, the state has recorded 67 life sciences company expansions and more than 10,000 announced jobs. In the past year alone, AbbVie, Genentech, J&J Innovative Medicine, and Novartis have all announced expansions, and FUJIFILM Biotechnologies opened its Holly Springs biomanufacturing facility. In the latest PharmaSource podcast episode, Bill explains what is drawing manufacturers to North Carolina, how the state keeps its talent pipeline ahead of demand, and where it still needs to catch up. Read the full article.


















